These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 9058592
21. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J. Cancer Res; 1990 Oct 15; 50(20):6565-70. PubMed ID: 2208117 [Abstract] [Full Text] [Related]
22. A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation. Capeáns C, Piñeiro A, Domínguez F, Loidi L, Buceta M, Carneiro C, Garcia-Caballero T, Sanchez-Salorio M. Exp Eye Res; 1998 May 15; 66(5):581-9. PubMed ID: 9628805 [Abstract] [Full Text] [Related]
23. The mitogenic response of T cells to interleukin-2 requires Raf-1. Riedel D, Brennscheidt U, Kiehntopf M, Brach M, Herrmann F. Eur J Immunol; 1993 Dec 15; 23(12):3146-50. PubMed ID: 8258328 [Abstract] [Full Text] [Related]
24. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides. Bertram J, Killian M, Brysch W, Schlingensiepen KH, Kneba M. Biochem Biophys Res Commun; 1994 Apr 15; 200(1):661-7. PubMed ID: 7909438 [Abstract] [Full Text] [Related]
27. A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells. Hofmann MH, Heinrich J, Radziwill G, Moelling K. Mol Cancer Res; 2009 Oct 15; 7(10):1635-44. PubMed ID: 19825990 [Abstract] [Full Text] [Related]
28. Molecular and cellular characterization of baboon C-Raf as a target for antiproliferative effects of antisense oligonucleotides. Mandiyan S, Schumacher C, Cioffi C, Sharif H, Yuryev A, Lappe R, Monia B, Hanson S, Goff S, Wennogle L. Antisense Nucleic Acid Drug Dev; 1997 Dec 15; 7(6):539-48. PubMed ID: 9450911 [Abstract] [Full Text] [Related]
33. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. J Clin Invest; 1994 Apr 25; 93(4):1458-64. PubMed ID: 8163650 [Abstract] [Full Text] [Related]
34. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Biro S, Fu YM, Yu ZX, Epstein SE. Proc Natl Acad Sci U S A; 1993 Jan 15; 90(2):654-8. PubMed ID: 8421701 [Abstract] [Full Text] [Related]
35. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Monia BP, Johnston JF, Geiger T, Muller M, Fabbro D. Nat Med; 1996 Jun 15; 2(6):668-75. PubMed ID: 8640558 [Abstract] [Full Text] [Related]
36. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. Monia BP, Sasmor H, Johnston JF, Freier SM, Lesnik EA, Muller M, Geiger T, Altmann KH, Moser H, Fabbro D. Proc Natl Acad Sci U S A; 1996 Dec 24; 93(26):15481-4. PubMed ID: 8986837 [Abstract] [Full Text] [Related]
37. Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance. Skutella T, Stöhr T, Probst JC, Ramalho-Ortigao FJ, Holsboer F, Jirikowski GF. Horm Metab Res; 1994 Oct 24; 26(10):460-4. PubMed ID: 7851868 [Abstract] [Full Text] [Related]
38. 2'-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotides. Griffey RH, Monia BP, Cummins LL, Freier S, Greig MJ, Guinosso CJ, Lesnik E, Manalili SM, Mohan V, Owens S, Ross BR, Sasmor H, Wancewicz E, Weiler K, Wheeler PD, Cook PD. J Med Chem; 1996 Dec 20; 39(26):5100-9. PubMed ID: 8978841 [Abstract] [Full Text] [Related]